Who owns QUALIGEN THERAPEUTICS INC?
- Ticker: AIXC
- CUSIP Number: 74754r301
Tip: Access positions for across all investors
Analyze quarterly positions in Qualigen Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Qualigen Therapeutics stock
Who bought or sold QUALIGEN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 71k | $88k | 455% | Mar 2026 |
|
| Vanguard Capital Management | 14k | $18k | 100% | Mar 2026 |
|
| Two Sigma Securities | 14k | $17k | 100% | Mar 2026 |
|
| Virtu Financial | 11k | $26k | 100% | Dec 2025 |
|
| Goldman Sachs Group | 11k | $14k | 100% | Mar 2026 |
|
| BlackRock | 501.00 | $625.999500 | 0% | Mar 2026 |
|
| Harbour Investments | 325.00 | $405.990000 | 0% | Mar 2026 |
|
| Tower Research Capital | 178.00 | $417.000600 | -57% | Dec 2025 |
|
| HighMark Wealth Management | 160.00 | $200.000000 | 0% | Mar 2026 |
|
| Group One Trading | 8.00 | $10.000000 | 0% | Mar 2026 |
|
| Us Bancorp | 7.00 | $15.999900 | 0% | Dec 2025 |
|
| SBI Securities | 6.00 | $7.999800 | 500% | Mar 2026 |
|
| UMA Financial Services | 2.00 | $3.000000 | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 2.00 | $5.000000 | 100% | Dec 2025 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | 100% | Mar 2026 |
|
| Danske Bank A/s | 1.00 | $1.000000 | 0% | Mar 2026 |
|
Who sold out of Qualigen Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Dec 2025 | 5.4k | $13k |